Participants 14 111 4
therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome.
Participants 183 275 4
plasma exchange (PE) and intravenous immunoglobulin (IVIg) for Guillian-Barre Syndrome (GBS)
Participants 294 360 5
64 adult patients with GBS for PE and IVIg treatment, respectively
